A Guide to the Lilly COI API


Click the image to view an infographic about the Lilly COI API

Click to enlarge the infographic.

Click to enlarge the infographic.

As the Internet continues to mature and more people access the web through desktop and mobile apps, the need for APIs (Application Programming Interfaces) has never been more pressing. APIs provide a consistent, easy-to-use way for developers to access data that can be built into mobile apps or websites.

Since 2005, ProgrammableWeb has cataloged the world’s APIs and has become the de facto journal of the API economy. Today there are more than 12,000 APIs listed in the ProgrammableWeb directory, but only 2.07% of those APIs are health-related. Clinical research-related APIs are hardly present at all, accounting for just 0.07% of the APIs listed on ProgrammableWeb.

The Lilly COI API is at the center of our efforts to make it easier for people to find clinical trials that are right for them or their loved ones. The API was created to make publicly-available clinical trial information easier for people to understand and easier for developers to work with.


Collaboration, Discovery and Insight through Open Data Initiatives 3

"Open Health: stethoscope" by Maria Boehling for opensource.com is licensed under CC-BY-2.0.

This work, “Open Health” is a deriviative of “Open Health: stethoscope” by Maria Boehling for opensource.com, used under CC-BY-2.0.

Last week, our friends at PACE Network USA were kind enough to invite me to write a guest blog for their site about open data initiatives and their potential impact on clinical trials. In the post, we mention OpenFDA as an example of the kinds of open data that could be a boon for health-related app developers and patients alike:

Simply put, open data initiatives like openFDA create new opportunities for collaboration, discovery and insight, and could greatly improve clinical trials by increasing researchers’ ability to learn from earlier studies and real-life occurrences. Projects like the American Society of Clinical Oncology’s CancerLinQ and Project Data Sphere (PDS) have already begun to change how oncologists share information with other oncologists. OpenFDA expands on these initiatives by allowing researchers from private companies and research institutions to easily access the wealth of information stored in the FDA’s archives. For patients, this can potentially accelerate access to lifesaving innovation. (from The FDA on Open Data)

Some developer teams have already taken on the task of developing web applications from the available FDA data. Social Health Insights, for example, created what is believed to be the first app based on OpenFDA data within hours of its release.


Happy Holidays! Reply

Illustration Copyright Ned Shaw, 2002 | The Scientist.com

Illustration Copyright Ned Shaw, 2002 | The Scientist.com

We’ve had an amazing 2013 and we can hardly wait to see what 2014 will bring!

As we look back on the past year, we’d like to thank everyone who has shared their stories and perspectives with us. We’ve had many “firsts” this year; we sponsored the Hoosier Code 4 Health codeathon, and the Clinical Trial Visualization Redesign Challenge for the first time,  and hosted our first Patients at the Center of Clinical Research Workshop.  We learned so much from each project, and we continue to learn from our friends and followers on Twitter every day.


Winners Selected in Clinical Trial Visualization Redesign Challenge! 3

Earlier this summer, we invited patients, healthcare professionals, web developers and designers to show us how they would present information about clinical trials is a more engaging and patient-friendly way through our Clinical Trial Visualization Redesign Challenge.

Today, we are pleased to announce the winners of that challenge. The eight submissions below represent the most innovative and user-friendly approaches to presenting clinical trial information, according to our judging panel of patient advocates and healthcare professionals; and, in the case of the Popular Vote Award, according to the public. The teams and  individuals who were selected were able to take complex, highly-technical, industry-focused  clinical trial documents and transform them into interactive, engaging, patient-focused platforms for discovering and understanding clinical research.

We also would like to take this opportunity to thank our judges for this challenge, who volunteered their time, skill and insight to helping us select the winners. Read more about each of them and their unique qualifications on the ChallengePost site.

And the Winners Are…